Table 1.
Clinical characteristics of EOC patients with high and low GAS5 risk scores
| Case(n) | GAS5 | P | ||
|---|---|---|---|---|
| Low-risk (n) | High-risk (n) | |||
| Age | ||||
| ≥ mean | 33 | 17 | 16 | 0.269 |
| < mean | 20 | 8 | 12 | |
| FIGO Stage | ||||
| I- II | 22 | 16 | 6 | 0.007* |
| III-IV | 31 | 10 | 21 | |
| Histological Type | ||||
| I | 11 | 7 | 4 | 0.024* |
| II- III | 42 | 16 | 26 | |
| Residual tumor (cm) | ||||
| < 1 cm | 34 | 18 | 16 | 0.332 |
| ≥ 1 cm | 19 | 8 | 11 | |
| Histology | ||||
| Mucinous | 7 | 3 | 4 | 0.402 |
| Serous | 41 | 17 | 24 | |
| Endometrioid | 3 | 1 | 2 | |
| Clear cell | 2 | 1 | 1 | |
| Lymphatic metastasis | ||||
| No | 20 | 8 | 12 | 0.257 |
| Yes | 33 | 14 | 19 | |
| Ascites | ||||
| No | 21 | 14 | 7 | 0.096 |
| Yes | 32 | 13 | 19 | |
P Values are calculated by X2 test or Fisher’s exact test